Open AccessEfficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels
Author(s) -
Guoliang Lv,
Wenjiang Ma,
Lin-Jung Ying,
Xi Jin,
Lin Zheng,
Yida Yang
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i32.4095
Subject(s) - telbivudine , hbeag , medicine , gastroenterology , hbsag , seroconversion , hepatitis b , hepatitis b virus , immunology , lamivudine , virus
To evaluate the efficacy and safety of telbivudine (LDT) in hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) patients who have high baseline alanine aminotransferase (ALT) levels between 10 and 20 times the upper limit of normal.